Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 208.49 and traded as high as GBX 216.50. Advanced Medical Solutions Group shares last traded at GBX 212.50, with a volume of 2,377,734 shares.

Analysts Set New Price Targets

Several research firms have weighed in on AMS. Peel Hunt reissued a “buy” rating and issued a GBX 246 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, September 17th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Advanced Medical Solutions Group currently has an average rating of “Buy” and an average price target of GBX 273.67.

Advanced Medical Solutions Group Stock Down 1.8%

The stock has a fifty day moving average of GBX 217.12 and a 200-day moving average of GBX 208.49. The firm has a market capitalization of £459.55 million, a price-to-earnings ratio of 50.96, a PEG ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings results on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. As a group, sell-side analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

Insider Buying and Selling

In other news, insider Eddie Johnson sold 18,726 shares of the company’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of GBX 220, for a total value of £41,197.20. Also, insider A Christopher (Chris) Meredith sold 50,510 shares of the firm’s stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of GBX 218, for a total transaction of £110,111.80. 4.12% of the stock is currently owned by company insiders.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.